Immunogenicity and Adverse Reactions to Biosimilar Erythropoietin Products in Thailand: The Significance of Science and Quality Driven Process for Approval
Crossref DOI link: https://doi.org/10.1007/978-3-319-99680-6_25
Published Online: 2018-12-14
Published Print: 2018
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Praditpornsilpa, Kearkiat
Assawamakin, Anunchai
Tungsanga, Kriang
Text and Data Mining valid from 2018-01-01